Allergy Diagnostics And Therapeutics

Allergy Diagnostics And Therapeutics Market Outlook

The global Allergy Diagnostics and Therapeutics Market is projected to reach approximately USD 56.2 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8.4% from 2025 to 2035. The increasing prevalence of allergies across various demographics, driven by environmental factors such as pollution and lifestyle changes, is one of the main growth factors influencing this market. In addition to this, there has been a rising awareness of allergy-related health issues, which propels the demand for effective diagnostic tools and therapeutic solutions. Technological advancements, such as the development of novel diagnostic devices and innovative therapeutic modalities, also contribute significantly to the market's expansion. Moreover, the growing healthcare expenditure in emerging economies reinforces the market growth as access to allergy diagnostics and therapeutic options becomes more prevalent.

Growth Factor of the Market

The growth of the Allergy Diagnostics and Therapeutics Market can be attributed to several significant factors. Firstly, the rising incidence of allergic conditions, including food allergies, respiratory allergies such as asthma, and various skin conditions, has escalated the demand for accurate and rapid diagnostic solutions. As more individuals are diagnosed and educated about their allergies, the necessity for effective treatments has surged, thereby boosting market growth. Secondly, advancements in technology have led to the emergence of innovative diagnostic tools, such as multiplex tests and microarray technology, which enhance the accuracy and efficiency of allergy testing. Additionally, increased consumer awareness and proactive health management have driven individuals to seek out diagnostic services and treatments for allergies. The growing focus on personalized medicine also plays a pivotal role, as tailored treatment approaches are being developed to cater to individual patients' needs. Lastly, the expansion of healthcare infrastructure in developing regions is creating new opportunities for the distribution and availability of allergy diagnostics and therapeutics, further supporting market growth.

Key Highlights of the Market

• The market is expected to witness significant growth due to rising allergy incidences worldwide.
• Technological advancements are enhancing the efficiency and accuracy of allergy diagnostics.
• Personalized medicine is shaping the future of allergy treatment modalities.
• Emerging markets are showing increased demand for allergy-related healthcare services.
• Growing awareness and education about allergies are driving market expansion.

By Product Type

In-vitro Diagnostics:

In-vitro diagnostics (IVD) are pivotal in the Allergy Diagnostics and Therapeutics Market, as they allow for the analysis of biological samples outside the body to detect allergic reactions accurately. These tests include specific IgE tests, skin prick tests, and component-resolved diagnostics, which provide crucial information about an individual’s sensitivities to various allergens. The growth in this segment is primarily driven by the increasing demand for precise testing methods that can facilitate effective diagnosis and subsequent management of allergies. Additionally, advancements in laboratory technologies, such as automated testing systems and enhanced reagent development, are further propelling this segment. As more healthcare providers adopt these diagnostic methods, the market for in-vitro diagnostics is expected to flourish.

In-vivo Diagnostics:

In-vivo diagnostics refer to tests conducted within the living organism to identify allergic conditions. Common in-vivo procedures include skin testing methodologies like intradermal tests and patch tests. The demand for in-vivo diagnostic techniques is growing, owing to their ability to provide immediate results and the ease of administration in clinical settings. Healthcare providers often prefer these methods due to their direct assessment of the body's response to allergens, leading to more accurate diagnoses. Furthermore, the rise in preventive healthcare awareness encourages individuals to undergo these tests, thus driving the growth of this segment in the Allergy Diagnostics and Therapeutics Market. Moreover, innovations in testing guidelines and protocols are improving patient outcomes, contributing to increased acceptance of in-vivo diagnostics.

By Application

Food Allergy:

The prevalence of food allergies has been rising globally, with significant implications for public health. As awareness of food allergies increases, there is a growing demand for effective diagnostic and therapeutic options tailored specifically to these conditions. This segment encompasses various testing methods for food allergens and therapies designed to mitigate reactions. The rising incidence of food allergies, particularly among children, has escalated research and development efforts to create safe and effective treatments, such as oral immunotherapy. Consequently, food allergy applications are becoming a crucial aspect of the Allergy Diagnostics and Therapeutics Market, fueling innovation and expanding the range of available solutions.

Respiratory Allergy:

Respiratory allergies, including allergic rhinitis and asthma, are among the most common allergic conditions worldwide. This segment is experiencing substantial growth due to the increasing prevalence of respiratory allergies and the growing public awareness regarding their management. The demand for rapid and accurate diagnostic tools, such as spirometry and peak flow meters, is on the rise, as they are essential for diagnosing and monitoring asthma and other respiratory conditions. Furthermore, therapies such as inhaled corticosteroids and biologics are becoming more available and effective, which enhances patient management. Overall, the respiratory allergy application plays a critical role in the Allergy Diagnostics and Therapeutics Market, driven by the need for effective solutions to improve the quality of life for millions affected by these conditions.

Drug Allergy:

Drug allergies represent a significant clinical concern, with a growing number of patients experiencing adverse reactions to various medications. This segment is fueled by increasing awareness among healthcare professionals and patients regarding drug allergies and the necessity for accurate diagnostics. Diagnostic methods, including skin tests and drug provocation tests, play an essential role in identifying specific drug sensitivities. With the development of new drugs and the complexity of polypharmacy in modern healthcare, the need for precise testing methods is more crucial than ever. In response to this demand, pharmaceutical companies are investing in research to better understand drug allergies, which is expected to significantly advance this segment of the Allergy Diagnostics and Therapeutics Market.

Skin Allergy:

Skin allergies, characterized by conditions such as eczema, urticaria, and contact dermatitis, are prevalent and can significantly impact patients' daily lives. The Allergy Diagnostics and Therapeutics Market is witnessing growth in this segment as individuals seek effective diagnostic methods and treatments to alleviate symptoms. Common diagnostic techniques such as patch testing and skin prick testing are crucial for identifying allergens responsible for skin reactions. Additionally, the development of topical and systemic treatments, including corticosteroids and antihistamines, is expanding the therapeutic options available for patients. As the understanding of skin allergies continues to evolve, this segment is becoming increasingly vital within the market, promoting innovation in both diagnostics and treatments.

Others:

This segment encompasses various other applications related to allergies, including insect sting allergies and latex allergies. While these applications may not be as prevalent as food or respiratory allergies, they still represent significant areas of concern for affected individuals. The demand for effective diagnostic techniques and therapeutic options continues to grow as awareness increases. Innovations in allergy testing and treatments in these niche areas contribute to the overall growth of the Allergy Diagnostics and Therapeutics Market. As healthcare providers expand their focus to address a broader range of allergic conditions, the "Others" category is expected to gain traction and enhance market dynamics.

By Distribution Channel

Hospitals:

Hospitals serve as a primary distribution channel for allergy diagnostics and therapeutics, providing a comprehensive range of services for allergy management. The presence of specialized departments and diagnostic labs enables hospitals to offer various testing and treatment options to patients. Furthermore, hospitals often have the advantage of integrated healthcare services, allowing for better follow-up and management of allergic conditions. With an increasing number of patients seeking allergy-related care in hospital settings, this channel is expected to witness a significant rise in demand. Hospitals are also investing in advanced diagnostic technologies, which further enhances their capabilities in allergy detection and treatment, thereby reinforcing their position in the market.

Clinics:

Clinics are essential distribution channels for allergy diagnostics and therapeutics, providing accessible services for patients seeking allergy evaluation and treatment. The rise of allergy-focused clinics and specialists has significantly increased the availability of allergy testing and personalized treatment plans. These clinics often offer a variety of diagnostic options, including skin tests and blood tests, that cater to patients' needs. Additionally, clinics are typically more accessible than hospitals, making it easier for patients to receive timely care. As patient awareness of allergies grows and the demand for convenient healthcare services increases, the role of clinics in the Allergy Diagnostics and Therapeutics Market is expected to expand considerably.

Diagnostic Laboratories:

Diagnostic laboratories are pivotal in the Allergy Diagnostics and Therapeutics Market, as they provide essential testing services to healthcare providers and patients. These laboratories specialize in conducting various allergy tests, including in-vitro and in-vivo diagnostics, and offer a range of advanced techniques to ensure accurate results. As the market demands more efficient and reliable testing methods, diagnostic laboratories are increasingly investing in state-of-the-art technology and automation to enhance their services. The rising preference for third-party laboratories by healthcare providers has also contributed to the growth of this distribution channel, as it allows for faster turnaround times and more comprehensive testing options.

Others:

The "Others" category in the distribution channel segment includes various platforms such as online pharmacies, retail pharmacies, and specialty allergy centers. These channels are becoming increasingly popular due to their convenience and accessibility, allowing patients to obtain diagnostic tests and therapeutic products without the need for a hospital visit. Online platforms, in particular, have gained traction in recent years, enabling patients to order allergy testing kits and medications from the comfort of their homes. As e-commerce continues to grow and shift consumer behavior towards more digital solutions, this segment is expected to play a crucial role in the overall Allergy Diagnostics and Therapeutics Market, expanding reach and accessibility for patients.

By Treatment Type

Antihistamines:

Antihistamines are among the most widely used therapeutic options for managing allergic reactions, offering relief from symptoms such as sneezing, itching, and runny nose. The growing demand for antihistamines is largely driven by their effectiveness and availability in both prescription and over-the-counter formats. As more individuals experience allergic conditions, particularly seasonal allergies, the use of antihistamines continues to rise. In addition, advancements in antihistamine formulations, such as non-drowsy options, are attracting patients seeking effective symptom relief without compromising their daily activities. Consequently, this treatment type is a significant contributor to the Allergy Diagnostics and Therapeutics Market.

Corticosteroids:

Corticosteroids are powerful anti-inflammatory medications used to manage severe allergic reactions and chronic conditions such as asthma and allergic rhinitis. This treatment type plays a vital role in controlling symptoms and reducing inflammation caused by allergic reactions. The increasing prevalence of chronic respiratory conditions has led to a growing need for corticosteroid treatments, driving market growth. Moreover, the development of new delivery methods, such as inhalers and nasal sprays, enhances the effectiveness of corticosteroids while improving patient compliance. The expanding array of corticosteroid options available in the market allows healthcare providers to tailor treatment plans for individual patients, further solidifying their importance in the Allergy Diagnostics and Therapeutics Market.

Decongestants:

Decongestants are commonly used to relieve nasal congestion associated with allergic rhinitis and other respiratory allergies. Their role in providing quick relief from symptoms like nasal blockage and sinus pressure has made them a popular choice among patients. The market for decongestants is growing due to the increasing incidence of allergic conditions and the rising awareness of available treatments. Furthermore, combination products that include antihistamines and decongestants are becoming more prevalent, offering patients a multi-faceted approach to managing their symptoms. The convenience and effectiveness of these treatments are driving demand within the Allergy Diagnostics and Therapeutics Market.

Immunotherapy:

Immunotherapy is an innovative treatment approach designed to desensitize patients to specific allergens over time. This method involves gradually exposing individuals to increasing amounts of allergens, allowing their immune systems to build tolerance. The growing popularity of immunotherapy is attributed to its long-lasting effects and potential to offer a permanent solution to allergy sufferers. As research continues to advance in this area, new forms of immunotherapy, such as sublingual tablets and monoclonal antibodies, are emerging, expanding treatment options for patients. This trend is expected to drive growth in the immunotherapy segment of the Allergy Diagnostics and Therapeutics Market, providing hope for long-term management of allergic conditions.

Others:

The "Others" category includes various treatment options not classified under the main types, such as herbal remedies, alternative therapies, and lifestyle modifications aimed at managing allergies. As patients increasingly seek holistic approaches to healthcare, the demand for alternative treatments is growing. This segment may encompass dietary interventions, acupuncture, and other non-traditional therapies. While these options may not have the extensive clinical backing of conventional treatments, their increasing popularity indicates a shift in patient preferences towards more integrated and personalized care. Consequently, the "Others" category is becoming an important aspect of the Allergy Diagnostics and Therapeutics Market, catering to diverse patient needs.

By Region

The Allergy Diagnostics and Therapeutics Market is witnessing significant regional variations in growth rates and demand for services. North America holds a substantial share of the market, driven by a high prevalence of allergic conditions and advanced healthcare infrastructure. The region is expected to maintain its leadership, supported by an increasing number of healthcare providers adopting innovative diagnostic and therapeutic solutions. Moreover, the region is projected to grow at a CAGR of around 7.8% during the forecast period, reflecting the ongoing efforts to improve allergy care and management. Furthermore, the growing awareness of allergies among the population is expected to contribute to the expansion of this market segment.

In Europe, the Allergy Diagnostics and Therapeutics Market is also experiencing notable growth, with the increasing recognition of allergies as a public health concern. The market is driven by the presence of well-established healthcare systems and a growing focus on preventive healthcare. The prevalence of respiratory and food allergies is considerably high in this region, prompting healthcare stakeholders to invest in better diagnostic and therapeutic options. Additionally, Asia Pacific is emerging as a promising region for market expansion due to a rising population, increasing urbanization, and growing healthcare expenditures. As awareness of allergies increases and healthcare access improves, the Allergy Diagnostics and Therapeutics Market in Asia Pacific is expected to witness rapid growth, further diversifying the global landscape.

Opportunities

The Allergy Diagnostics and Therapeutics Market is poised to benefit significantly from emerging opportunities as the burden of allergic diseases continues to rise. One of the most promising areas lies in the development of advanced diagnostic technologies that leverage artificial intelligence and machine learning to enhance the accuracy and speed of allergy testing. These innovations can lead to more personalized treatment plans and improved patient outcomes. Additionally, as telemedicine gains traction, remote consultations and online allergy testing services present convenient options for patients, especially in underserved areas. By expanding access to allergy diagnostics and treatment options, these trends can help bridge gaps in healthcare delivery and improve overall patient care.

Moreover, the increasing focus on preventive healthcare presents further opportunities for growth in the Allergy Diagnostics and Therapeutics Market. Healthcare providers are increasingly recognizing the importance of early diagnosis and management of allergies to prevent severe allergic reactions and long-term complications. This shift encourages the development of preventive strategies and educational campaigns that promote awareness and proactive health management. As more individuals seek out preventive allergy assessments and treatments, the market is expected to expand further, paving the way for innovative solutions and enhancing the overall healthcare landscape for allergy management.

Threats

Despite the promising growth prospects for the Allergy Diagnostics and Therapeutics Market, several threats could hinder its progress. One of the most significant challenges is the increasing regulatory scrutiny surrounding allergy testing and therapeutic products. Stringent regulations can create barriers to market entry for new devices and treatments, limiting innovation and the availability of novel solutions. Additionally, the complexity of allergen identification and the variability in individual responses to allergies may challenge the development of standardized diagnostic and treatment protocols. As a result, the market could face difficulties in ensuring consistency and reliability in allergy management across different patient populations.

Furthermore, the rising cost of healthcare services and treatments may pose a threat to market accessibility. Patients, particularly in low- and middle-income regions, may face financial barriers in obtaining allergy diagnostics and therapeutics, leading to underdiagnosis and undertreatment of allergic conditions. This situation can perpetuate the cycle of inadequate allergy management and increase the burden of allergies on healthcare systems. Addressing these economic challenges will be essential in ensuring that all patients have access to the necessary diagnostic and therapeutic options in the Allergy Diagnostics and Therapeutics Market.

Competitor Outlook

• Thermo Fisher Scientific
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Merck Group
• Danaher Corporation
• Hoffmann-La Roche AG
• Bio-Rad Laboratories
• Genzyme Corporation
• BD (Becton, Dickinson and Company)
• Alcon Inc.
• Johnson & Johnson
• GlaxoSmithKline
• Sanofi S.A.
• Novartis AG

The competitive landscape of the Allergy Diagnostics and Therapeutics Market is characterized by a mix of established players and emerging companies, all vying for a share of this rapidly expanding market. Key players are focusing on strategic partnerships, mergers, and acquisitions to enhance their product offerings and expand their market presence. For instance, collaborations between diagnostic companies and research institutions are fostering innovation in allergy testing technologies, while partnerships with healthcare providers aim to improve patient access to allergy management solutions. Additionally, companies are increasingly investing in research and development activities to introduce novel diagnostic tools and therapeutic options that address the evolving needs of patients.

Leading companies such as Thermo Fisher Scientific and Roche Diagnostics have established themselves as frontrunners in the Allergy Diagnostics and Therapeutics Market. These companies are known for their extensive portfolios of diagnostic solutions, cutting-edge technologies, and commitment to research and development. Thermo Fisher Scientific, for example, offers a wide range of allergy testing kits and platforms that utilize advanced immunoassay techniques, enabling accurate and efficient allergen detection. Similarly, Roche Diagnostics is recognized for its innovative diagnostic solutions that cater to diverse allergy-related conditions, providing healthcare professionals with essential tools for patient management.

Moreover, emerging players in the market are also making significant strides by leveraging technology and focusing on niche areas of allergy diagnostics and therapeutics. Companies such as Genzyme Corporation and Bio-Rad Laboratories are investing in personalized medicine approaches and developing targeted therapies that address specific allergic conditions. These innovative offerings are expected to enhance patient outcomes and set new standards for allergy management. As the competitive landscape continues to evolve, it will be essential for companies to stay ahead of market trends and consumer preferences to maintain their positions in the Allergy Diagnostics and Therapeutics Market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Alcon Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck Group
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Novartis AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sanofi S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GlaxoSmithKline
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Roche Diagnostics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Danaher Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Genzyme Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hoffmann-La Roche AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Siemens Healthineers
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Allergy Diagnostics And Therapeutics Market, By Application
    • 6.1.1 Food Allergy
    • 6.1.2 Respiratory Allergy
    • 6.1.3 Drug Allergy
    • 6.1.4 Skin Allergy
    • 6.1.5 Others
  • 6.2 Allergy Diagnostics And Therapeutics Market, By Product Type
    • 6.2.1 In-vitro Diagnostics
    • 6.2.2 In-vivo Diagnostics
  • 6.3 Allergy Diagnostics And Therapeutics Market, By Treatment Type
    • 6.3.1 Antihistamines
    • 6.3.2 Corticosteroids
    • 6.3.3 Decongestants
    • 6.3.4 Immunotherapy
    • 6.3.5 Others
  • 6.4 Allergy Diagnostics And Therapeutics Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Diagnostic Laboratories
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Allergy Diagnostics And Therapeutics Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Allergy Diagnostics And Therapeutics market is categorized based on

By Product Type

• In-vitro Diagnostics
• In-vivo Diagnostics

By Application

• Food Allergy
• Respiratory Allergy
• Drug Allergy
• Skin Allergy
• Others

By Distribution Channel

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

By Treatment Type

• Antihistamines
• Corticosteroids
• Decongestants
• Immunotherapy
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Merck Group
• Danaher Corporation
• Hoffmann-La Roche AG
• Bio-Rad Laboratories
• Genzyme Corporation
• BD (Becton, Dickinson and Company)
• Alcon Inc.
• Johnson & Johnson
• GlaxoSmithKline
• Sanofi S.A.
• Novartis AG